verapamil - CISMeF

Preferred Label : verapamil;

MeSH definition : A calcium channel blocker that is a class IV anti-arrhythmia agent.;

MeSH synonym : iproveratril;

CISMeF synonym : sandoz brand of verapamil; verapamil sandoz brand;

MeSH hyponym : verapamil hydrochloride; falicard; Lekoptin; izoptin; calan; cordilox; finoptin; Hydrochloride, Verapamil; Isoptine; Isoptin;

Related MeSH term : dexverapamil;

MeSH CAS label : benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-;

MeSH Related Number : lekoptin; 52-53-9 (Verapamil); dexverapamil; verapamil hydrochloride; 152-11-4; QR5PYD126V; V3888OEY5R;

Registry Number MeSH : 52-53-9;

Related CAS MeSH : 152-11-4 (Lekoptin); QR5PYD126V (Dexverapamil); V3888OEY5R (Verapamil hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Verapamil;

Codes EINECS : 200-145-1;

Is substance : O;

UNII : CJ0O37KU29;

InChIKey : SGTNSNPWRIOYBX-UHFFFAOYSA-N;

Details

Origin ID

D014700;

UMLS CUI

C0042523;

ATC code(s)
- trandolapril and verapamil [ATC Code]
- verapamil [ATC Code]
- verapamil, combinations [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Dexverapamil [NCIt concept]
- Iproveratril [ICHI extension code]
- Lekoptin [International Nonproprietary Name]
- Verapamil Hydrochloride [NCIt concept]
- Verapamil hydrochloride (substance) [SNOMED CT concept]
- verapamil hydrochloride [Substance BNPC]
- verapamil hydrochloride [SNOMED Notion]
CISMeF manual mappings
- verapamil [Substance BNPC]
Pharmacological action(s)
- anti-arrhythmia agents [MeSH Descriptor]
- calcium channel blockers [MeSH Descriptor]
- vasodilator agents [MeSH Descriptor]
Record concept(s)
- Lekoptin [MeSH concept]
- calan [MeSH concept]
- cordilox [MeSH concept]
- dexverapamil [MeSH concept]
- falicard [MeSH concept]
- finoptin [MeSH concept]
- izoptin [MeSH concept]
- verapamil [MeSH concept]
- verapamil hydrochloride [MeSH concept]
Related MeSH Supplementary Concept(s)
- (N-benzoyl)-5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropyl-N-4-azidobenzoylpentylamine [MeSH Supplementary Concept]
- 1-hydroxy-2,2,5,5-tetramethyl-2,5-diydro-1H-pyrrole-3-carboxylic acid (2-(3,4-dimethoxyphenyl)-5-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)-2-isopropylpentyl)amide [MeSH Supplementary Concept]
- 1-hydroxy-2,2,6,6-tetramethyl-1,2,3,6-tetrahydro-pyridine-4-carboxylic acid-(2-(3,4-dimethoxyphenyl)-5-(2-(3,4-dimethoxyphenyl)ethyl)methylamino)-2-isopropyl-pentylamide [MeSH Supplementary Concept]
- 2-(2-isopropyl)-5-hydroxy-2-phenylpentanenitrile [MeSH Supplementary Concept]
- 2-(3,4-dimethoxyphenyl)-5-amino-2-isopropylvaleronitrile [MeSH Supplementary Concept]
- 2-(3,4-dimethoxyphenyl)-5-methylamino-2-isopropylvaleronitrile [MeSH Supplementary Concept]
- 2-(3,4-dimethoxyphenyl)-8-(4-hydroxy-3-methoxyphenyl)-6-methyl-2-isopropyl-6-azaoctanitrile [MeSH Supplementary Concept]
- 4-desmethoxyverapamil [MeSH Supplementary Concept]
- 5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylpentyl isothiocyanate [MeSH Supplementary Concept]
- CL 347099 [MeSH Supplementary Concept]
- CVAD-V protocol [MeSH Supplementary Concept]
- D 595 [MeSH Supplementary Concept]
- D 703 [MeSH Supplementary Concept]
- EDP 96 [MeSH Supplementary Concept]
- HO-4038 [MeSH Supplementary Concept]
- KR 30032 [MeSH Supplementary Concept]
- KR 30035 [MeSH Supplementary Concept]
- KR30031 [MeSH Supplementary Concept]
- LU 49888 [MeSH Supplementary Concept]
- MKV4 compound [MeSH Supplementary Concept]
- PB-3 flush solution [MeSH Supplementary Concept]
- alpha-(3-((2-(4-hydroxy-3,5-diiodophenyl)ethyl)methylamino)propyl) -3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile [MeSH Supplementary Concept]
- alpha-(3-aminopropyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile [MeSH Supplementary Concept]
- bodipy-verapamil [MeSH Supplementary Concept]
- carboxyverapamil [MeSH Supplementary Concept]
- devapamil [MeSH Supplementary Concept]
- emopamil [MeSH Supplementary Concept]
- nexopamil [MeSH Supplementary Concept]
- noremopamil [MeSH Supplementary Concept]
- norverapamil [MeSH Supplementary Concept]
- osaka university cocktail [MeSH Supplementary Concept]
- phenoptin [MeSH Supplementary Concept]
- quinidine, verapamil drug combination [MeSH Supplementary Concept]
- ro 44-5911 [MeSH Supplementary Concept]
- ro 44-5912 [MeSH Supplementary Concept]
- stenoptin [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Dexverapamil Hydrochloride [NCIt concept]
- Product containing verapamil (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing verapamil (medicinal product) [SNOMED CT concept]
- Verapamil [ICD-11 Extension code]
- Verapamil [NCIt concept]
- Verapamil [LOINC component]
- Verapamil (substance) [SNOMED CT concept]
- verapamil [ATC Code]
- verapamil [Substance BNPC]
- verapamil [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients